RCT's specialized licensing programs deliver relevant and versatile technologies to corporate R&D and manufacturing operations worldwide. RCT's unmatched licensing expertise moves new and mature technologies into the widest commercial use possible.

The Gene eXpression Technologies licensing program is gathering many of the world's most popular gene expression systems, tool and genes into one convenient and affordable licensing program for the biotechnology industry. The program offers flexible, nonexclusive licenses with manageable fees and fractional royalties dependent on fields of use.

Our Blue Noise Mask team developed a substantial portfolio of patents for the landmark halftoning technology and licensed it to printing industry leaders including Hewlett-Packard Company, Seiko Epson Corporation and Lexmark. These licensing efforts are ongoing.

RCT also is offering nonexclusive licenses to a landmark ultrasound tissue harmonic imaging technology that had been adopted widely in various platforms. RCT is in discussions with numerous companies in the industry.